Shilpa Medicare receives EIR for API manufacturing facilities in Karnataka

11 Jul 2018 Evaluate

Shilpa Medicare has received EIR (Establishment Inspection Report) from US Food and Drug Administration (USFDA) to both API manufacturing facilities located at Raichur, Karnataka. This inspection was carried out on January 16-19, 2018. The inspection has now been closed by USFDA.

Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Share Price

319.85 -0.65 (-0.20%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×